The following adverse effects may occur with lornoxicam tablets: Common (≥1/100, 1/10): Mild short-term headache, dizziness, nausea, abdominal pain, indigestion, diarrhea, vomiting.
Uncommon (≥1/1,000, 1/100): Loss of appetite, weight changes, insomnia, depression, conjunctivitis, vertigo, tinnitus, palpitations, tachycardia, swelling, fluid retention, heart failure, redness of the face, rhinitis, constipation, flatulence, belching, dry mouth, gastritis, stomach and duodenal ulcers, abdominal pain, gum bleeding, ulcerative stomatitis, increase in serum transaminase levels (ALT, AST), rashes, itching, increased sweating, erythematous rashes, urticaria and angioedema, al petsiya, arthralgia, malaise, swelling of the face.
Rare (≥1/10,000, 1/1,000): Pharyngitis, anemia, thrombocytopenia, eosinophilia, leukopenia, coagulation disorder, pancytopenia, hypersensitivity reactions, fever, chills, anaphylactoid reactions, anaphylaxis, hyponatremia, anxiety, impaired consciousness, increased excitability, impaired ability to concentrate, changes in attention, cognitive disorders, drowsiness, paresthesia, dysgeusia, tremor, migraine, hyperkinesia, hypoesthesia, visual impairment, including blurring of vision, changes of color perception, visual field defects, scotoma, amblyopia, diplopia, iridocyclitis, arterial hypertension, hot flashes, venostasis, vasculitis, hematomas, dyspnoea, cough, bronchospasm, melena, vomiting with blood, stomatitis, esophagitis, gastroesophageal reflux disease, dysphagia, aphthous stomatitis, glossitis, perforation of peptic ulcers, hemorrhoids, gastrointestinal bleeding, dermatitis, eczema, maculopapular rash, purpura, pain sensation in the bones and back, muscle spasms, muscle weakness, myalgia, synovitis, nocturia, urinary disorders, increased urea and creatinine in the blood, asthenia.
Very rare (˂1/10,000): Ecchymosis, aseptic meningitis in patients with systemic lupus erythematosus and mixed connective tissue diseases, toxic effects on the liver, resulting in the development of hepatic insufficiency, hepatitis, jaundice, cholestasis, edema and bullous reactions, nail changes, psoriasis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, lornoxicam can cause acute renal failure in patients with pre-existing kidney disease.
Seek medical attention immediately at the first sign of any adverse drug reaction shall appear.
View ADR Reporting Link